Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Constellation Brands $400 million senior notes offering
The investment-grade notes are due 2029
Banco de Crédito del Perú $500 million and S/1.15 billion notes offerings
We advised BCP on the takedowns under its MTN program
OPKO Health $230 million convertible senior notes offering
The 3.75% convertible notes are due 2029
Grayscale Bitcoin Trust approved as world’s largest bitcoin ETF
We advised Grayscale in the yearslong effort to secure SEC approval for the NYSE Arca listing
Auna $550 million secured term loan refinancing
We advised Auna on the transaction
Sumitomo Mitsui Trust Bank $1.5 billion senior notes offering
We advised Sumitomo Mitsui Trust Bank on the update of its global MTN program and senior notes offering
CCC Intelligent Solutions Holdings $230 million secondary offering
The shares are listed on the Nasdaq Global Select Market
Toyota Motor Credit $3 billion notes offering
We advised Toyota Motor Credit on the SEC-registered notes offering
Solid Biosciences $109 million private placement
The PIPE includes common stock and pre-funded warrants
Olema Pharmaceuticals $150 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market